Bee venom (BV) has been used as an anti-inflammatory and immune modulating agent in Oriental medicine. This study used a mouse model to investigate the anti-allergic effect of BV, which is used in the treatment of various inflammatory diseases in traditional medicine. BV was obtained from the National Institute of Agricultural Science and Technology of Korea. Female BALB/C mice were sensitized by intraperitoneal injection of ovalbumin (OVA). BV was administered nasally prior to the intranasal instillation of OVA. Allergic behavior, serum OVA-specific immunoglobulin E (IgE), interleukin (IL)-4, IL-10, and interferon-gamma (INF-γ) levels in nasal lavage fluid were measured. Hematoxylin-eosin and periodic acid-Schiff staining were performed to evaluate histological change. BV attenuated nasal symptoms and inhibited the production of OVA-specific IgE and IL-4 in sensitized mice. The degree of inflammatory cell infiltration and goblet cell hyperplasia was attenuated by BV. Thus, BV effectively reduced allergic inflammation in a mouse model of allergic rhinitis, suggesting its potential as a useful therapeutic agent to treat allergic rhinitis.Key words bee venom; allergic rhinitis; ovalbumin; mouse model Allergic rhinitis (AR) is characterized by nasal mucosal inflammation resulting from immunoglobulin E (IgE) mediated hypersensitivity reaction. Allergen exposures stimulate infiltration of inflammatory cells within the nasal mucosa, including basophils, eosinophils, mast cells, and mononuclear cells. These inflammatory cells release several allergic mediators, such as histamine, cysteinyl leukotrienes, and prostaglandins, which sustain the inflammatory reaction and produce characteristic nasal symptoms of, sneezing, itching, rhinorrhea and nasal congestion. Animal models of the allergic response to inhaled allergens have been studied to elucidate the mechanisms leading to the development of inflammation and the therapeutic effect of newly developed anti-inflammatory agents. Repeated exposure of mice to ovalbumin (OVA) has been used to develop an allergic model with inflammatory cell infiltration and increased thickness of the epithelial layer.
1)Bee venom (BV) consists of a various biologically active amines, peptides and nonpeptide components, and has radioprotective, antimutagenic, anti-inflammatory, antinociceptive, and anticancer activities.2,3) Two main components of BV, melittin and adolapin, have anti-inflammatory activity that involve inhibition of cycloxygease-2 and, phospholipase A 2 expression, and decrease levels of tumor necrosis factor-α, interleukin (IL)-1, IL-6, and nitric oxide.4) The anti-allergic activity is associated with marked inhibition of OVA-induced tracheal contraction and histamine release from lung tissue. The mast-cell degranulating peptide binds to the mast cell receptors and inhibits the binding of IgE and production of histamine.5) BV also inhibits the release of inflammatory mediators similar to nonsteroidal anti-inflammatory drugs.The anti-inflammatory effect of BV includes airborne ...